$SNGX
SOLIGENIX, INC.

2024 Q1 Form 10-K Financial Statement

#000155837024003402 Filed on March 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $117.0K $244.8K $839.4K
YoY Change -54.49% -33.12% -11.54%
Cost Of Revenue $117.0K $221.6K $742.1K
YoY Change -48.23% 63.06% 34.72%
Gross Profit $0.00 $23.26K $97.31K
YoY Change -100.0% -89.9% -75.56%
Gross Profit Margin 0.0% 9.5% 11.59%
Selling, General & Admin $1.022M $1.384M $4.483M
YoY Change -17.27% -4.08% -33.03%
% of Gross Profit 5948.41% 4606.46%
Research & Development $1.095M $777.5K $3.313M
YoY Change 15.7% -67.02% -58.3%
% of Gross Profit 3342.78% 3404.27%
Depreciation & Amortization $1.590K $1.590K $6.550K
YoY Change -11.17% -47.35% -73.33%
% of Gross Profit 6.84% 6.73%
Operating Expenses $2.117M $2.161M $7.795M
YoY Change -2.97% -43.13% -46.74%
Operating Profit -$2.117M -$2.138M -$7.698M
YoY Change -1.56% -40.12% -45.94%
Interest Expense $28.84K -$295.0K -$4.580K
YoY Change -127.85% 59.15% -99.44%
% of Operating Profit
Other Income/Expense, Net $201.8K $6.400K $187.8K
YoY Change -456.37% 253.59% -126.29%
Pretax Income -$1.915M -$2.427M -$7.909M
YoY Change -13.23% -35.35% -47.11%
Income Tax $0.00 -$606.6K -$1.768M
% Of Pretax Income
Net Earnings -$1.915M -$1.820M -$6.141M
YoY Change 83.09% -51.52% -55.5%
Net Earnings / Revenue -1636.63% -743.39% -731.6%
Basic Earnings Per Share -$0.18 -$0.79
Diluted Earnings Per Share -$0.18 -$0.17 -$0.79
COMMON SHARES
Basic Shares Outstanding 10.52M 10.38M 7.758M
Diluted Shares Outstanding 10.52M 7.758M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.092M $8.446M $8.446M
YoY Change -30.92% -36.78% -36.78%
Cash & Equivalents $7.092M $8.446M $8.446M
Short-Term Investments
Other Short-Term Assets $584.6K $866.0K $866.0K
YoY Change 174.03% 215.82% 215.82%
Inventory
Prepaid Expenses $451.9K $866.0K
Receivables $117.0K $171.3K $171.3K
Other Receivables $25.25K $23.90K $23.90K
Total Short-Term Assets $7.818M $9.507M $9.507M
YoY Change -27.08% -31.37% -31.37%
LONG-TERM ASSETS
Property, Plant & Equipment $10.34K $241.8K $241.8K
YoY Change -38.07% 1208.15% -32.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $29.09K $48.25K $48.25K
YoY Change -40.78% -28.09% -28.09%
Total Long-Term Assets $240.0K $290.0K $290.0K
YoY Change -36.82% -32.01% -32.01%
TOTAL ASSETS
Total Short-Term Assets $7.818M $9.507M $9.507M
Total Long-Term Assets $240.0K $290.0K $290.0K
Total Assets $8.058M $9.797M $9.797M
YoY Change -27.41% -31.39% -31.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.437M $1.111M $1.111M
YoY Change -48.11% -71.25% -71.25%
Accrued Expenses $2.603M $2.791M $2.791M
YoY Change 6.18% 20.94% 1.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.996M $2.250M $2.250M
YoY Change -50.06% -77.27% -77.27%
Total Short-Term Liabilities $7.211M $6.152M $6.152M
YoY Change -36.62% -62.75% -62.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.011M $1.011M
YoY Change -100.0%
Other Long-Term Liabilities $79.13K $111.9K $111.9K
YoY Change -61.26% -52.12% -52.12%
Total Long-Term Liabilities $79.13K $1.123M $1.123M
YoY Change -97.46% 380.58% 380.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.211M $6.152M $6.152M
Total Long-Term Liabilities $79.13K $1.123M $1.123M
Total Liabilities $7.290M $7.275M $7.275M
YoY Change -49.69% -56.57% -56.57%
SHAREHOLDERS EQUITY
Retained Earnings -$227.6M -$225.7M
YoY Change 3.18% 2.8%
Common Stock $10.52K $10.38K
YoY Change 259.18% 256.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $768.4K $2.522M $2.522M
YoY Change
Total Liabilities & Shareholders Equity $8.058M $9.797M $9.797M
YoY Change -27.41% -31.39% -31.39%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.915M -$1.820M -$6.141M
YoY Change 83.09% -51.52% -55.5%
Depreciation, Depletion And Amortization $1.590K $1.590K $6.550K
YoY Change -11.17% -47.35% -73.33%
Cash From Operating Activities -$1.342M -$1.828M -$8.604M
YoY Change -38.03% -49.6% -31.98%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.59M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.992K -46.18K 3.664M
YoY Change -99.03% -160.11% 4668.89%
NET CHANGE
Cash From Operating Activities -1.342M -1.828M -8.604M
Cash From Investing Activities
Cash From Financing Activities -8.992K -46.18K 3.664M
Net Change In Cash -1.355M -1.874M -4.941M
YoY Change -56.21% -47.21% -61.05%
FREE CASH FLOW
Cash From Operating Activities -$1.342M -$1.828M -$8.604M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.81
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7758036
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2871345
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000812796
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10378238
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2908578
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023 us-gaap Collaborative Arrangement Transaction Statement Of Income Or Comprehensive Income Extensible Enumeration
CollaborativeArrangementTransactionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#Revenues
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-14778
CY2023 dei Entity Registrant Name
EntityRegistrantName
SOLIGENIX, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1505029
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
29 EMMONS DRIVE
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE B-10
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
PRINCETON
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08540
CY2023 dei City Area Code
CityAreaCode
609
CY2023 dei Local Phone Number
LocalPhoneNumber
538-8200
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023 dei Trading Symbol
TradingSymbol
SNGX
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
6846887
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10524437
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
274
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8446158
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2022Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
115130
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
171254
CY2023Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
23894
CY2022Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
104198
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
866014
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274209
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9507320
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13853152
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
22777
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
22777
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
121320
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114766
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11927
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18481
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
20206
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
229834
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340987
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
25468
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
24114
CY2023Q4 us-gaap Assets
Assets
9797326
CY2022Q4 us-gaap Assets
Assets
14279717
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1111226
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3865796
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2418002
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2307746
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
251115
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
336692
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
121765
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
108948
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
102309
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2250000
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
9897691
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6152108
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16516873
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
1010934
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
111862
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
233627
CY2023Q4 us-gaap Liabilities
Liabilities
7274904
CY2022Q4 us-gaap Liabilities
Liabilities
16750500
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
43
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
350000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10378238
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2908578
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10378
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2909
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
228193977
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217064964
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22243
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
24747
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-225704176
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219563446
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2522422
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2470826
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9797326
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14279717
CY2023 us-gaap Revenues
Revenues
839359
CY2022 us-gaap Revenues
Revenues
948911
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
742048
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
550822
CY2023 us-gaap Gross Profit
GrossProfit
97311
CY2022 us-gaap Gross Profit
GrossProfit
398089
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3312699
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7944089
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4482552
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6692904
CY2023 us-gaap Operating Expenses
OperatingExpenses
7795251
CY2022 us-gaap Operating Expenses
OperatingExpenses
14636993
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7697940
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-14238904
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1483
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-30549
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-49129
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-822611
CY2023 sngx Uk Research And Development Incentives
UkResearchAndDevelopmentIncentives
-23784
CY2022 sngx Uk Research And Development Incentives
UkResearchAndDevelopmentIncentives
-132869
CY2023 sngx Employee Retention Credit Cares Act
EmployeeRetentionCreditCaresAct
120771
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43223
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5921
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-393791
CY2023 sngx Fair Value Adjustment Of Convertible Debt
FairValueAdjustmentOfConvertibleDebt
-43066
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-210593
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-714370
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7908533
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14953274
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1767803
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1154935
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6140730
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13798339
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.81
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7758036
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2871345
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6140730
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13798339
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2504
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17195
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6143234
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13815534
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10722598
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
212003
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
333389
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17195
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13798339
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2470826
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3299
CY2023 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
50000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
370182
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2504
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6140730
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2522422
CY2023 us-gaap Profit Loss
ProfitLoss
-6140730
CY2022 us-gaap Profit Loss
ProfitLoss
-13798339
CY2023 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
6554
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
24562
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
111153
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
112714
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
370182
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
333389
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
73000
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
212003
CY2023 sngx Issuance Of Common Stock For Purchase Option
IssuanceOfCommonStockForPurchaseOption
50000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-393791
CY2023 sngx Fair Value Adjustment Of Convertible Debt
FairValueAdjustmentOfConvertibleDebt
-43066
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12518
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
41538
CY2023 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
56124
CY2022 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-23759
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
591805
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8694
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-90016
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-73374
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-108948
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-111122
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2685073
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
396651
CY2023 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-85577
CY2022 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
33756
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8604109
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12649021
CY2022 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
13073
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13073
CY2023 sngx Proceeds From Issuance Of Common Stock Pursuant To Market Sales Agreement
ProceedsFromIssuanceOfCommonStockPursuantToMarketSalesAgreement
3091462
CY2022 sngx Proceeds From Issuance Of Common Stock Pursuant To Market Sales Agreement
ProceedsFromIssuanceOfCommonStockPursuantToMarketSalesAgreement
79354
CY2023 sngx Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
8495817
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
7000000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3663506
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76821
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27146
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-99009
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4913457
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12684282
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26043897
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8446158
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
20730
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
16043
CY2023 us-gaap Interest Paid Net
InterestPaidNet
552058
CY2022 us-gaap Interest Paid Net
InterestPaidNet
857411
CY2023 sngx Operating Lease Paid
OperatingLeasePaid
133817
CY2022 sngx Operating Lease Paid
OperatingLeasePaid
133300
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
347546
CY2023 sngx Noncash Or Part Noncash Deferred Issuance Cost Reclassified To Additional Paid In Capital
NoncashOrPartNoncashDeferredIssuanceCostReclassifiedToAdditionalPaidInCapital
20208
CY2022 sngx Noncash Or Part Noncash Deferred Issuance Cost Reclassified To Additional Paid In Capital
NoncashOrPartNoncashDeferredIssuanceCostReclassifiedToAdditionalPaidInCapital
60
CY2022 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
43
CY2023 sngx Redemption Of Preferred Stock
RedemptionOfPreferredStock
43
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-225704176
CY2023Q4 sngx Working Capital Carrying Value
WorkingCapitalCarryingValue
3355212
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-6140730
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8604109
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8446158
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4913457
CY2023 sngx Percentage Change In Cash And Cash Equivalents
PercentageChangeInCashAndCashEquivalents
0.37
CY2023Q4 sngx Working Capital Carrying Value
WorkingCapitalCarryingValue
3355212
CY2022Q4 sngx Working Capital Carrying Value
WorkingCapitalCarryingValue
-2663721
CY2022 sngx Working Capital Increase Decrease
WorkingCapitalIncreaseDecrease
6018933
CY2022 sngx Working Capital Percentage Increase Decrease
WorkingCapitalPercentageIncreaseDecrease
2.26
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q4 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
3260934
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
25%
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
25%
CY2023 sngx Share Based Compensation Arrangement Service Period
ShareBasedCompensationArrangementServicePeriod
P3Y
CY2023 sngx Sharebased Compensation Expiration Period
SharebasedCompensationExpirationPeriod
P10Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.94
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.10
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.87
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0348
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0435
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0112
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0451
CY2023 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1483
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
30549
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1767803
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1154935
CY2023 sngx Net Operating Loss Carryforwards Sold
NetOperatingLossCarryforwardsSold
606606
CY2022Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023Q4 sngx Research And Development Incentive Receivable
ResearchAndDevelopmentIncentiveReceivable
49000
CY2022Q4 sngx Research And Development Incentive Receivable
ResearchAndDevelopmentIncentiveReceivable
128000
CY2022Q4 sngx Incentives
Incentives
128312
CY2023 sngx Uk Research And Development Incentive
UKResearchAndDevelopmentIncentive
24897
CY2023 sngx Additional Incentive Received
AdditionalIncentiveReceived
-1113
CY2023 sngx Uk Research And Development Incentives Cash Receipt
UKResearchAndDevelopmentIncentivesCashReceipt
-104422
CY2023 sngx Foreign Currency Translation
ForeignCurrencyTranslation
1688
CY2023Q4 sngx Incentives
Incentives
49362
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9559368
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
355542
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates and Assumptions</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions such as the fair value of warrants and stock options and to accrue for clinical trials in process that affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
229834
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340987
CY2023Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
233627
CY2022Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
342575
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
136917
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
116250
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19540
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
233627
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0847
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P22M
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106155
CY2022Q2 sngx Increase In Right Of Use Lease Asset Lease Extension
IncreaseInRightOfUseLeaseAssetLeaseExtension
347546
CY2022 sngx Operating Lease Right Of Use Asset Reduction Amortization
OperatingLeaseRightOfUseAssetReductionAmortization
-112714
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340987
CY2023 sngx Operating Lease Right Of Use Asset Reduction Amortization
OperatingLeaseRightOfUseAssetReductionAmortization
-111153
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
229834
CY2021Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
106151
CY2022Q2 sngx Increase In Operating Lease Liability Lease Extension
IncreaseInOperatingLeaseLiabilityLeaseExtension
347546
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
111122
CY2022Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
342575
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
108948
CY2023Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
233627
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
134892
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
134892
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
136022
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
136022
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1993784
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1884117
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
424218
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
423629
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2418002
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2307746
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2520808
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
766012
CY2023Q4 sngx Total Long Term
TotalLongTerm
3286820
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2023Q4 sngx Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
2310677
CY2023 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2022 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2023 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-1767803
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-1154935
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1767803
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1154935
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27522000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27252000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8921000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8837000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
246000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
285000
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1409000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1696000
CY2023Q4 sngx Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
2311000
CY2022Q4 sngx Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
1832000
CY2023Q4 sngx Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
66000
CY2022Q4 sngx Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
96000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-12000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40463000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
39998000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40398000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39902000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
65000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
96000
CY2023Q4 sngx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
65000
CY2022Q4 sngx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
96000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
65000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
96000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
123000000.0
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
12900000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3700000
CY2023Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
8900000
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1767803
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1154935
CY2023 sngx Net Operating Loss Carryforwards Sold
NetOperatingLossCarryforwardsSold
606606
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3908
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.216
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.024
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.002
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.020
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.039
CY2023 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.009
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.031
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.007
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.004
CY2023 sngx Effectiveincometaxratereconciliationexpirationoftaxattributes
Effectiveincometaxratereconciliationexpirationoftaxattributes
0.142
CY2022 sngx Effectiveincometaxratereconciliationexpirationoftaxattributes
Effectiveincometaxratereconciliationexpirationoftaxattributes
0.091
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.063
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.068
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.224
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.077
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.46
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5377
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.30
CY2022Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6411
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.80
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3664
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
13.65
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1667
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.20
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5129
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.75
CY2023 sngx Share Based Compensation Arrangement By Share Based Payment Award Number Of Equity Programs
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEquityPrograms
4
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140996
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.12
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
55730
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.85
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
107.83
CY2022 sngx Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
545
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
333389
CY2023Q4 us-gaap Assets
Assets
9797326
CY2022Q4 us-gaap Assets
Assets
14279717
CY2022 sngx Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
11.70
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
192273
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.56
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
731544
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.65
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
16925
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
34.71
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
906892
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.73
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
370182
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
333389
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
421000
CY2023 sngx Payment For Commitment Milestones
PaymentForCommitmentMilestones
13200000
CY2023 sngx Percentage Of Sub License Income Royalties
PercentageOfSubLicenseIncomeRoyalties
0.15
CY2023Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
6200
CY2022Q2 sngx Lease Rental Per Month
LeaseRentalPerMonth
11367
CY2023Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
182917
CY2023Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
162250
CY2023Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
46000
CY2023Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
46000
CY2023Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
46000
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
483167
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023 us-gaap Revenues
Revenues
839359
CY2022 us-gaap Revenues
Revenues
948911
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7697940
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-14238904
CY2023 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
6554
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
24562
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-210593
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-714370
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
370182
CY2023 dei Auditor Name
AuditorName
Cherry Bekaert LLP
CY2023 dei Auditor Location
AuditorLocation
Tampa, Florida

Files In Submission

Name View Source Status
0001558370-24-003402-index-headers.html Edgar Link pending
0001558370-24-003402-index.html Edgar Link pending
0001558370-24-003402.txt Edgar Link pending
0001558370-24-003402-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sngx-20231231.xsd Edgar Link pending
sngx-20231231x10k.htm Edgar Link pending
sngx-20231231x10k004.jpg Edgar Link pending
sngx-20231231x10k005.jpg Edgar Link pending
sngx-20231231xex19d1.htm Edgar Link pending
sngx-20231231xex21d1.htm Edgar Link pending
sngx-20231231xex23d1.htm Edgar Link pending
sngx-20231231xex23d2.htm Edgar Link pending
sngx-20231231xex31d1.htm Edgar Link pending
sngx-20231231xex31d2.htm Edgar Link pending
sngx-20231231xex32d1.htm Edgar Link pending
sngx-20231231xex32d2.htm Edgar Link pending
sngx-20231231xex4d1.htm Edgar Link pending
sngx-20231231xex97.htm Edgar Link pending
sngx-20231231_lab.xml Edgar Link unprocessable
sngx-20231231_def.xml Edgar Link unprocessable
sngx-20231231x10k_htm.xml Edgar Link completed
sngx-20231231_cal.xml Edgar Link unprocessable
sngx-20231231_pre.xml Edgar Link unprocessable